NDAINJECTIONINJECTABLEPriority Review
Approved
Mar 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 9h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CLAFORAN (cefotaxime sodium) is a third-generation cephalosporin antibiotic administered by injection for treatment of serious bacterial infections including meningitis, sepsis, and hospital-acquired infections. It works by inhibiting bacterial cell wall synthesis, making it bactericidal against a broad spectrum of gram-positive and gram-negative organisms. This legacy injectable antibiotic has been a foundational therapy in hospital and critical care settings for over 40 years.
LOE Approaching
As an approaching LOE product with moderate competitive pressure (30%), the brand team is likely in defensive/maintenance mode with emphasis on hospital formulary retention and cost-effectiveness positioning against generics.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Roles on CLAFORAN are primarily commercial-operations and hospital-focused, emphasizing formulary access, pricing negotiations, and generic competition management rather than innovation or patient engagement. Career growth is constrained by the product's mature LOE status and limited clinical development opportunities, making this a stabilization rather than growth assignment.
Hospital Account Manager
Worked on CLAFORAN at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.